U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"I watched his countenance closely, to see if he was not deranged ... and I was assured by other senators after he left the room that they had no confidence in it."

U.S. Senator Smith of Indiana ; After seeing Samuel Morse demonstrate the telegraph.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 424/78.14 - Nitrogen heterocycle


Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the adsorbate or treating agent contains
No. of patents: 35
Last issue date: 06/21/2011


NumberTitleIssue Date
7964181Amino acid surrogates for peptidic constructs
Ring-constrained amino acid surrogates of formula I: where R1, R2, R3, R4, R5, R6a, R6b, R7, and y are as defined in the specification,...
06/21/2011
7238348Method of treatment of osteoporosis with compositions of red rice fermentation products
Methods are disclosed for using red rice fermentation products for the treatment or prevention of osteoporosis and abnormal bone mass conditions. Particular Monascus strains yield fermentation products with the desired biological activities. ...
07/03/2007
7175856Palatable oral suspension and method
A drug formulation in the form of a dry powder is provided which when mixed with water forms a palatable oral suspension substantially free of bitter taste, the dry powder being formed of a drug, preferably des-quinolone, which in solution has a bitter taste, and a ...
02/13/2007
7138122Therapeutic systems
A compound comprising a target cell-specific portion and human NAD(P)H:quinone reductase 2 (NQO2) or a variant or fragment or fusion or derivative thereof which has substantially the same activity as NQO2 towards a given prodrug, or a polynucleotide encoding said NQ...
11/21/2006
7087223Preventives and/or remedies for hyperphosphatemia
Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect...
08/08/2006
6867231Therapeutic systems
A compound comprising a target cell-specific portion and human NAD(P)H:quinone reductase 2 (NQO2) or a variant or fragment or fusion or derivative thereof which has substantially the same activity as NQO2 towards a given prodrug, or a polynucleotide encoding said NQ...
03/15/2005
6844372Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
An cross-linked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having two or more functional groups capable of reacting with amino and/or ...
01/18/2005
6692732Ionic polymers as toxin-binding agents
A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c...
02/17/2004
6610284Preparation for prevention and healing of inflammation affections
A preparation for prevention and healing of inflammation affections comprising in an amount of 0.1 to 99.9% by weight derivatives of sterically hindered amines selected from the group consisting of: soluble polymers or copolymers prepared by radical polym...
08/26/2003
6514492Taste masking of oral quinolone liquid preparations using ion exchange resins
This invention relates to the formulation of oral liquid products of quinolones or derivatives thereof using ion exchange resins, such as methacrylic acid polymer crosslinked with divinylbenzene, as the carrier, thereby eliminating the extreme bitterness ...
02/04/2003
6290947Ionic polymers as toxin-binding agents
A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c...
09/18/2001
6084005Antimicrobial caries-detecting composition
An antimicrobial caries-detecting composition, which comprises(i) water, a water-miscible solvent or a combination thereof, (ii) a dye capable of staining the caries-infected portions of teeth, and (iii) at least one antimicrobial agent....
07/04/2000
6007803Ionic polymers as toxin binding agents
A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c...
12/28/1999
5935604Nasal drug delivery composition containing nicotine
The present invention provides a nasal drug delivery composition comprising nicotine or a pharmacologically-acceptable salt or derivative thereof wherein the composition is adapted to delivery a pulse of nicotine for rapid absorption and a controlled rele...
08/10/1999
5888526Antibacterial antifungal agent and fibrous material containing the same
The present invention is to provide a fibrous material containing an antibacterial antifungal agent consisting of specific metal salt of organic compound effective for both antibacterial and antifungal functions and various articles containing the same fi...
03/30/1999
5874522Crosslinked polymeric ammonium salts
Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ...
02/23/1999
5861437Polyphenylene ether resin
A poly(phenylene ether) resin composed of structural units represented by the general formula: ##STR1## (wherein R1, R2 and R3 represent each alkyl, cycloalkyl, etc. or H (provided that two or more of R1, R...
01/19/1999
5726284Crosslinked polymric ammonium salts
Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ...
03/10/1998
5575993Ionene polymers containing biologically-active anions
Ionene polymers having biologically-active organic and/or inorganic anions are described. Methods to prepare the ionene polymers, compositions containing them and their methods of use are also described....
11/19/1996
5516881Aminoxyl-containing radical spin labeling in polymers and copolymers
Aminoxyl-containing radical is provided in polymers and copolymers by replacing a hydroxyl moiety in a carboxyl group at a chain end of a starting material biodegradable polymer or copolymer with imino or oxy linked to aminoxyl-containing radical to form ...
05/14/1996
5505952Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
Synthetic, cross-linked amino-acid containing polymers are useful in forming medical devices. The hydrogels of the invention are particularly useful in wound healing and anti-adhesion applications....
04/09/1996
5498409Material for adsorbing pyrogen
An insoluble material for adsorbing a pyrogen comprising a polymer of an aziridine compound. According to the present invention, a large amount of the pyrogen can be easily removed from a solution containing pyrogen, and a large amount of the material for...
03/12/1996
5496819Antiphlogistic-analgesic plaster comprising triacetin and piroxicam
An antiphlogistic-analgesic plaster comprising piroxicam and triacetin and/or triethyl citrate. The antiphlogistic-analgesic plaster of the invention is excellent in percutaneous absorption of piroxicam and hence has an excellent antiphlogistic and analge...
03/05/1996
5460807Antiproliferative oligomers
The oligomers of the present invention are polyureas or polyamides having a number average molecular weight of
10/24/1995
5447726Orally administrable cholesterol lowering agent
There is provided an orally administrable cholesterol lowering agent which is obtained by coating with hydroxypropylmethylcellulose plain tablets containing an anion exchange resin as an active component and containing 14-20% by weight of water and not mo...
09/05/1995
5401499Method of adsorbing pyrogens
An insoluble material for adsorbing a pyrogen comprising a polymer of an aziridine compound. According to the present invention, a large mount of the pyrogen can be easily removed from a solution containing pyrogen, and a large amount of the material for ...
03/28/1995
5246698Biocompatible viscoelastic gel slurries, their preparation and use
Disclosed are biocompatible viscoelastic gel slurries formed from a polymeric gel, preferably a hyaluronan or a derivative thereof such as hylan swollen in an aqueous medium and a fluid phase which is an aqueous solution of a polymer which may also but no...
09/21/1993
5209922Water soluble polymers having antifungal properties
This invention relates to an antifungal block copolymer of poly(vinyl lactam) having the formula ##STR1## where m has a value of from 1 to 3 and from about 15 to about 25 wt. % of a quaternized amino alkyl acrylamide comonomer wherein the quaternizin...
05/11/1993
5152986Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives
Known antibacterial quinolonecarboxylic acid derivatives such as ciprofloxacin are administered to animals in their food in the form of weak cation exchangers loaded therewith. The taste is much improved and the animals accept the material more readily....
10/06/1992
5143724Biocompatible viscoelastic gel slurries, their preparation and use
Disclosed are biocompatible viscoelastic gel slurries formed from a polymeric gel, preferably a hyaluronan or a derivative thereof such as hylan swollen in an aqueous medium and a fluid phase which is an aqueous solution of a polymer which may also but no...
09/01/1992
4996047Sustained release drug-resin complexes
Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subseq...
02/26/1991
4843130Antibacterial polymer
An antibacterial polymer containing a repeating unit of the formula ##STR1## wherein A, l and n are defined in the specification....
06/27/1989
4788055Resinate sustained release dextromethorphan composition
A pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been cross-linked with about 3% to about 10% divinyl benzene, having an average particle size of at least 48 μm and less...
11/29/1988
4780322Method of producing slow-release pharmaceutical forms
The invention relates to a novel method of producing slow-release pharmaceutical forms administered per os, by simultaneously employing two resins having anionic character, the proportions of said resins being variable. By varying the ratio of the amounts...
10/25/1988
4578268Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
There are provided palatable anthelmintic resinate compositions for companion animals, containing anthelmintically effective amounts of a styrylpyridinium compound and/or an N,N-dialkylpiperazine carboxamide....
03/25/1986
 
Sign InRegister
Username  
Password   
forgot password?